Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Long Term Ceftibuten for Pyelonephritis in Children
NCT00724256Phase 3Terminated
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Jul 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ceftibuten in pyelonephritis, sponsored by IRCCS Burlo Garofolo. Started Jul 2006; status: terminated.
02
Drugs
ceftibuten
03
Conditions
pyelonephritis
Beyond the preview
Go deeper on NCT00724256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724256.